BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Staging
25 results:

  • 1. MYL9 expressed in cancer-associated fibroblasts regulate the immune microenvironment of colorectal cancer and promotes tumor progression in an autocrine manner.
    Deng S; Cheng D; Wang J; Gu J; Xue Y; Jiang Z; Qin L; Mao F; Cao Y; Cai K
    J Exp Clin Cancer Res; 2023 Nov; 42(1):294. PubMed ID: 37926835
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Reticulon 2 promotes gastric cancer metastasis via activating endoplasmic reticulum Ca
    Song S; Liu B; Zeng X; Wu Y; Chen H; Wu H; Gu J; Gao X; Ruan Y; Wang H
    Cell Death Dis; 2022 Apr; 13(4):349. PubMed ID: 35428758
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stathmin 1 is a biomarker for diagnosis of microvascular invasion to predict prognosis of early hepatocellular carcinoma.
    Cai Y; Fu Y; Liu C; Wang X; You P; Li X; Song Y; Mu X; Fang T; Yang Y; Gu Y; Zhang H; He Z
    Cell Death Dis; 2022 Feb; 13(2):176. PubMed ID: 35210426
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. UNC5B-AS1 promotes the proliferation, migration and emt of hepatocellular carcinoma cells via regulating miR-4306/KDM2A axis.
    Huang X; Pan J; Wang G; Huang T; Li C; Wang Y; Li X
    Cell Cycle; 2021 Oct; 20(20):2114-2124. PubMed ID: 34612138
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.
    Xu J; Zhang Y; Liu C; Yan P; Yang Z
    Int J Med Sci; 2021; 18(15):3556-3564. PubMed ID: 34522182
    [No Abstract]    [Full Text] [Related]  

  • 6. [Application of MRI-based Radiomics Models in the Assessment of Hepatic Metastasis of Rectal cancer].
    Hu SX; Yang K; Wang XR; Wen DG; Xia CC; Li X; Li ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 52(2):311-318. PubMed ID: 33829708
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The cross-talk between DDR1 and STAT3 promotes the development of hepatocellular carcinoma.
    Lin Y; Jin H; Wu X; Jian Z; Zou X; Huang J; Guan R; Wei X
    Aging (Albany NY); 2020 Jul; 12(14):14391-14405. PubMed ID: 32716315
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Impact of E-cadherin and its transcription regulators on assessing epithelial-mesenchymal transition in chronic hepatitis C virus infection.
    Hassan M; Aboushousha T; El-Ahwany E; Khalil HK; Montasser AY; Abu-Taleb H; El-Talkawy MD; Zoheiry M
    Minerva Gastroenterol (Torino); 2021 Jun; 67(2):175-182. PubMed ID: 32677416
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF1.
    Peng J; Wu HJ; Zhang HF; Fang SQ; Zeng R
    Clin Transl Oncol; 2021 Mar; 23(3):468-480. PubMed ID: 32617870
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Inhibition of PRRX2 suppressed colon cancer liver metastasis via inactivation of Wnt/β-catenin signaling pathway.
    Chai WX; Sun LG; Dai FH; Shao HS; Zheng NG; Cai HY
    Pathol Res Pract; 2019 Oct; 215(10):152593. PubMed ID: 31471104
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. CDX1 Expression Induced by CagA-Expressing
    Choi SI; Yoon C; Park MR; Lee D; Kook MC; Lin JX; Kang JH; Ashktorab H; Smoot DT; Yoon SS; Cho SJ
    Mol Cancer Res; 2019 Nov; 17(11):2169-2183. PubMed ID: 31416838
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Upregulated MMP28 in Hepatocellular Carcinoma Promotes Metastasis via Notch3 Signaling and Predicts Unfavorable Prognosis.
    Zhou J; Zheng X; Feng M; Mo Z; Shan Y; Wang Y; Jin J
    Int J Biol Sci; 2019; 15(4):812-825. PubMed ID: 30906212
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. PEA15 promotes liver metastasis of colorectal cancer by upregulating the ERK/MAPK signaling pathway.
    Tang B; Liang W; Liao Y; Li Z; Wang Y; Yan C
    Oncol Rep; 2019 Jan; 41(1):43-56. PubMed ID: 30365128
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.
    Li W; Yu ZX; Ma BF
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5490-5498. PubMed ID: 30229820
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma.
    Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ
    Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses.
    Yin LC; Luo ZC; Gao YX; Li Y; Peng Q; Gao Y
    Biomed Res Int; 2018; 2018():3789613. PubMed ID: 30046595
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. 18F-Fluorodeoxyglucose uptake on positron emission tomography/computed tomography is associated with metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Lee M; Jeon JY; Neugent ML; Kim JW; Yun M
    Clin Exp Metastasis; 2017 Apr; 34(3-4):251-260. PubMed ID: 28429188
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
    Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.